Dietary serine and glycine restriction delays cancer-associated cachexia

Cancer is often thought of as a disease of the body's own cells turning against the patient, but its most devastating effect is frequently a systemic collapse known as cachexia. This condition is not simply a loss of appetite or a failure to eat enough; it is a complex metabolic syndrome where the body begins to consume its own fat and muscle, leading to severe weakness and a reduced ability to tolerate treatment. For decades, medical efforts to reverse this wasting have focused on feeding patients more nutrients, yet these conventional dietary approaches have largely failed to stop the decline. The prevailing view has been that the tumor drives this destruction, and that the only way to help the host is to starve the cancer or simply provide more fuel. However, a new line of inquiry suggests that the body's response to specific nutrients might be just as critical as the tumor's growth, and that the solution to wasting might lie not in adding more food, but in carefully removing specific components from the diet.

Researchers at the Francis Crick Institute in London have investigated whether restricting two specific building blocks of life, the amino acids serine and glycine, could alter the course of cancer in mice. In a series of experiments involving different types of lung and pancreatic cancer, they discovered that a diet lacking these two nutrients triggers a profound shift in the host's metabolism. This shift does not merely slow the tumor; it fundamentally changes how the body handles stress and inflammation, effectively delaying the onset of wasting even when the cancer itself continues to grow. The findings suggest that the key to surviving cancer may involve retraining the body's metabolic resilience rather than just attacking the tumor directly.

To understand how this works, the team first observed what happens to healthy mice when they are fed a diet without serine and glycine. These animals did lose some weight, but the loss was almost entirely due to a reduction in body fat, while their muscle mass and strength remained intact. The mice ate less, particularly during their active night hours, and their bodies adapted by burning fat more efficiently. Crucially, this leaner state did not make them sick; they remained active and healthy, suggesting that the body could adapt to this nutrient restriction without suffering the usual consequences of starvation. This established a baseline: removing these amino acids creates a specific metabolic state in the host that is distinct from simple malnutrition.

The researchers then introduced tumors into these mice to see how this dietary state would interact with cancer. They used two different models of lung cancer. In the first model, the tumors were sensitive to the diet, meaning the lack of serine and glycine slowed the cancer's growth. In this case, the mice lived longer, and their weight loss was delayed. However, the more surprising discovery came from the second model, where the tumors were completely resistant to the diet. The cancer in these mice grew just as fast as it did in mice eating a normal diet, and the tumors were the same size when the animals reached the end of the study. Yet, despite the identical tumor burden, the mice on the restricted diet did not waste away. They maintained their body weight and fat stores much longer than the control group. This proved that the protection against wasting was not a side effect of the tumor shrinking; it was a direct result of the host's body adapting to the diet.

Digging deeper into the biology of these protected mice, the team found that the liver was the primary site of this metabolic reprogramming. In the mice on the restricted diet, the liver increased its production of glutathione, a powerful antioxidant that protects cells from damage. Simultaneously, the liver shifted its processing of fats, breaking down lipids in a way that reduced the accumulation of toxic, oxidized byproducts. In the control mice, the presence of the tumor led to a buildup of these harmful lipid species and a surge in systemic inflammation, which is a known driver of muscle and fat loss. The restricted diet effectively dampened this inflammatory fire. The mice had lower levels of inflammatory signals in their blood, fewer immune cells rushing to the tumor, and less evidence of oxidative stress throughout their bodies.

To confirm that inflammation was the key driver of the wasting, the researchers treated a separate group of mice with a powerful anti-inflammatory drug called dexamethasone. Even though these mice were eating a normal diet, the drug mimicked the protective effects of the restricted diet. The treated mice retained more of their body fat and had lower levels of inflammatory markers, just like the mice on the serine and glycine-free diet. This experiment linked the two phenomena: the diet worked because it suppressed the inflammatory cascade that normally triggers the body to consume itself. The researchers also noted that the diet reduced the levels of specific cytokines, which are chemical messengers that signal the body to break down tissue, further supporting the idea that the diet acts as a brake on the wasting process.

The study also looked at pancreatic cancer, a disease known for being particularly aggressive and resistant to dietary changes. Even in this model, where the tumor did not respond to the lack of serine and glycine, the mice on the restricted diet fared better than those on a standard diet. They lost less visceral fat, maintained better muscle function, and showed lower levels of stress markers in their blood. The diet appeared to induce a state of metabolic resilience in the host, making the body less susceptible to the toxic signals emitted by the tumor. This suggests that the approach could be broadly useful, potentially helping patients with various types of cancer that do not respond to direct metabolic targeting.

The implications of these findings challenge the long-held assumption that the only way to combat cancer-related wasting is to increase caloric intake. Instead, the data points to a model where limiting specific nutrients can prime the host's metabolism to withstand the stress of the disease. By reducing oxidative stress and calming the inflammatory response, the diet allows the body to preserve its energy stores and muscle mass for longer. While the study was conducted in mice and further research is needed to determine if these results translate to humans, the work offers a new perspective on cancer care. It suggests that the battle against cancer is not just about the tumor, but about the metabolic environment in which it grows, and that carefully curating that environment could provide a powerful tool to improve the quality of life for patients facing this devastating disease.